Novartis Sheds Vildagliptin Trademark In India Ahead Of Patent Expiry

Trees
Novartis Assigns Vildagliptin Trademark In India To Eris
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category